{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:16:22Z","timestamp":1790936182125,"version":"4.1.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2008,1,23]],"date-time":"2008-01-23T00:00:00Z","timestamp":1201046400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0001465","type":"journal-article","created":{"date-parts":[[2008,1,22]],"date-time":"2008-01-22T23:26:54Z","timestamp":1201044414000},"page":"e1465","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":75,"title":["Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial"],"prefix":"10.1371","volume":"3","clinical-trial-number":[{"clinical-trial-number":"nct00308061","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Mahamadou A.","family":"Thera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ogobara K.","family":"Doumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drissa","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dapa A.","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdoulaye K.","family":"Kone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ando B.","family":"Guindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Traore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alassane","family":"Dicko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issaka","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahamadou S.","family":"Sissoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mounirou","family":"Baby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mady","family":"Sissoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issa","family":"Diarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amadou","family":"Niangaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amagana","family":"Dolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modibo","family":"Daou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sory I.","family":"Diawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Gray","family":"Heppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Ann","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Angov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke S.","family":"Bergmann-Leitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Lanar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheetij","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Soisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carter L.","family":"Diggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Leach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Owusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason N.","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aric","family":"Gregson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon L.","family":"Takala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten E.","family":"Lyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher V.","family":"Plowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2008,1,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","article-title":"Efficacy of the RTS,S\/AS02A vaccine against <italic>Plasmodium falciparum<\/italic> infection and disease in young African children: randomised controlled trial.","volume":"364","author":"PL Alonso","year":"2004","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(05)67669-6","article-title":"Duration of protection with RTS,S\/AS02A malaria vaccine in prevention of <italic>Plasmodium falciparum<\/italic> disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.","volume":"366","author":"PL Alonso","year":"2005","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(07)61542-6","article-title":"Safety of the RTS,S\/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I\/IIb trial.","volume":"370","author":"JJ Aponte","year":"2007","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.vaccine.2005.01.142","article-title":"Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.","volume":"23","author":"DG Heppner Jr","year":"2005","journal-title":"Vaccine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1128\/IAI.01879-06","article-title":"Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S\/AS01B boosting significantly improves immunogenicity to <italic>Plasmodium falciparum<\/italic> CS compared to that with either malaria vaccine alone.","volume":"75","author":"VA Stewart","year":"2007","journal-title":"Infect Immun"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.micinf.2007.02.006","article-title":"Obstacles to the development of a safe and effective attenuated pre-erythrocytic stage malaria vaccine.","volume":"9","author":"BW Ripley","year":"2007","journal-title":"Microbes Infect"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1242\/jeb.00644","article-title":"Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated <italic>Plasmodium falciparum<\/italic> sporozoite vaccine.","volume":"206","author":"TC Luke","year":"2003","journal-title":"J Exp Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0166-6851(94)90096-5","article-title":"Differential localization of full-length and processed forms of PF83\/AMA-1 an apical membrane antigen of <italic>Plasmodium falciparum<\/italic> merozoites.","volume":"67","author":"DL Narum","year":"1994","journal-title":"Mol Biochem Parasitol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"15119","DOI":"10.1074\/jbc.273.24.15119","article-title":"Precise timing of expression of a <italic>Plasmodium falciparum<\/italic>-derived transgene in Plasmodium berghei is a critical determinant of subsequent subcellular localization.","volume":"273","author":"CH Kocken","year":"1998","journal-title":"J Biol Chem"},{"key":"ref10","first-page":"297","article-title":"Rat monoclonal antibodies which inhibit the in vitro multiplication of <italic>Plasmodium knowlesi<\/italic>.","volume":"49","author":"JA Deans","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0166-6851(84)90112-9","article-title":"The Fab fragments of monoclonal IgG to a merozoite surface antigen inhibit <italic>Plasmodium knowlesi<\/italic> invasion of erythrocytes.","volume":"13","author":"AW Thomas","year":"1984","journal-title":"Mol Biochem Parasitol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1128\/IAI.69.5.3286-3294.2001","article-title":"Specificity of the protective antibody response to apical membrane antigen 1.","volume":"69","author":"AN Hodder","year":"2001","journal-title":"Infect Immun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"12295","DOI":"10.1073\/pnas.2032858100","article-title":"Invasion-inhibitory antibodies inhibit proteolytic processing of apical membrane antigen 1 of <italic>Plasmodium falciparum<\/italic> merozoites.","volume":"100","author":"S Dutta","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.4269\/ajtmh.1994.51.730","article-title":"High prevalence of natural antibodies against <italic>Plasmodium falciparum<\/italic> 83-kilodalton apical membrane antigen (PF83\/AMA-1) as detected by capture-enzyme-linked immunosorbent assay using full-length baculovirus recombinant PF83\/AMA-1.","volume":"51","author":"AW Thomas","year":"1994","journal-title":"Am J Trop Med Hyg"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4269\/ajtmh.2001.65.100","article-title":"Longitudinal study of natural immune responses to the <italic>Plasmodium falciparum<\/italic> apical membrane antigen (AMA-1) in a holoendemic region of malaria in western Kenya: Asembo Bay Cohort Project VIII.","volume":"65","author":"V Udhayakumar","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0166-6851(01)00229-8","article-title":"Polymorphism in the gene encoding the apical membrane antigen-1 (AMA-1) of <italic>Plasmodium falciparum<\/italic>. X. Asembo Bay Cohort Project.","volume":"113","author":"AA Escalante","year":"2001","journal-title":"Mol Biochem Parasitol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1128\/IAI.71.3.1416-1426.2003","article-title":"Geographical structure of diversity and differences between symptomatic and asymptomatic infections for <italic>Plasmodium falciparum<\/italic> vaccine candidate AMA1.","volume":"71","author":"A Cortes","year":"2003","journal-title":"Infect Immun"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1365-2958.2003.03974.x","article-title":"Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in <italic>Plasmodium falciparum<\/italic>.","volume":"52","author":"J Healer","year":"2004","journal-title":"Mol Microbiol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1128\/IAI.70.12.6948-6960.2002","article-title":"In vitro studies with recombinant <italic>Plasmodium falciparum<\/italic> apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response.","volume":"70","author":"MC Kennedy","year":"2002","journal-title":"Infect Immun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/IAI.70.8.4471-4476.2002","article-title":"High-level expression of the malaria blood-stage vaccine candidate <italic>Plasmodium falciparum<\/italic> apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion.","volume":"70","author":"CH Kocken","year":"2002","journal-title":"Infect Immun"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.vaccine.2007.03.012","article-title":"Phase I dose escalation safety and immunogenicity trial of <italic>Plasmodium falciparum<\/italic> apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naive adults at the Walter Reed Army Institute of Research.","volume":"25","author":"ME Polhemus","year":"2007","journal-title":"Vaccine"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1128\/IAI.73.6.3677-3685.2005","article-title":"Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for <italic>Plasmodium falciparum<\/italic> malaria.","volume":"73","author":"EM Malkin","year":"2005","journal-title":"Infect Immun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1128\/IAI.70.6.3101-3110.2002","article-title":"Purification, characterization, and immunogenicity of the refolded ectodomain of the <italic>Plasmodium falciparum<\/italic> apical membrane antigen 1 expressed in Escherichia coli.","volume":"70","author":"S Dutta","year":"2002","journal-title":"Infect Immun"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2004.01.054","article-title":"Incidence of severe <italic>Plasmodium falciparum<\/italic> malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali.","volume":"22","author":"KE Lyke","year":"2004","journal-title":"Vaccine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4269\/ajtmh.2002.67.604","article-title":"Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali.","volume":"67","author":"D Coulibaly","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1086\/430707","article-title":"Community permission for medical research in developing countries.","volume":"41","author":"DA Diallo","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.4049\/jimmunol.148.5.1519","article-title":"Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine.","volume":"148","author":"JY Wu","year":"1992","journal-title":"J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1749-6632.1993.tb44041.x","article-title":"Adjuvant activity of QS-21 isomers.","volume":"690","author":"S Soltysik","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"ref29","article-title":"Miniaturization of a high throughput pLDH-based <italic>Plasmodium falciparum<\/italic> growth inhibition assay for small volume samples from preclinical and clinical vaccine trials.","author":"E Bergmann-Leitner","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4269\/ajtmh.1990.43.243","article-title":"In vitro growth inhibition of <italic>Plasmodium falciparum<\/italic> by sera from different regions of the Philippines.","volume":"43","author":"NE Sy","year":"1990","journal-title":"Am J Trop Med Hyg"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1371\/journal.pctr.0010034","article-title":"Safety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a Phase I randomized trial.","volume":"1","author":"MA Thera","year":"2006","journal-title":"PLoS Clin Trials"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1371\/journal.pctr.0010032","article-title":"Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized Phase Ib dose-escalation trial in Kenyan children.","volume":"1","author":"MR Withers","year":"2006","journal-title":"PLoS Clin Trials"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"12488","DOI":"10.1073\/pnas.0701464104","article-title":"Structural basis of antigenic escape of a malaria vaccine candidate.","volume":"104","author":"S Dutta","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1016\/j.vaccine.2006.06.033","article-title":"Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S\/AS02A.","volume":"24","author":"VA Stewart","year":"2006","journal-title":"Vaccine"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0001465","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T15:28:03Z","timestamp":1708529283000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0001465"}},"subtitle":[],"editor":[{"given":"Colin","family":"Sutherland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,1,23]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,1,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0001465","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,23]]}}}